A citation-based method for searching scientific literature

Solange Peters, Olivier Michielin, Stefan Zimmermann. J Clin Oncol 2013
Times Cited: 76

Gerald S Falchook, Georgina V Long, Razelle Kurzrock, Kevin B Kim, Tobias H Arkenau, Michael P Brown, Omid Hamid, Jeffrey R Infante, Michael Millward, Anna C Pavlick, Steven J O'Day, Samuel C Blackman, C Martin Curtis, Peter Lebowitz, Bo Ma, Daniele Ouellet, Richard F Kefford. Lancet 2012
Times Cited: 689

List of shared articles

Times cited

Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib.
Oliver Gautschi, Solange Peters, Vincent Zoete, Franziska Aebersold-Keller, Klaus Strobel, Bernhard Schwizer, Astrid Hirschmann, Olivier Michielin, Joachim Diebold. Lung Cancer 2013

Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene.
Nathaniel J Myall, Joel W Neal, Cheryl D Cho-Phan, Lisa Y Zhou, Henning Stehr, Li Zhou, Maximilian Diehn, Heather A Wakelee. Clin Lung Cancer 2016

Molecular Markers in the Diagnosis and Treatment of Cancer.
Murat Gokden, Aurelio Ariza, Konstantinos Arnaoutakis. Biomed Res Int 2015

BRAF: A Two-Faced Janus.
Pasquale Pisapia, Francesco Pepe, Antonino Iaccarino, Roberta Sgariglia, Mariantonia Nacchio, Gianluca Russo, Gianluca Gragnano, Umberto Malapelle, Giancarlo Troncone. Cells 2020

BRAF Alterations as Therapeutic Targets in Non-Small-Cell Lung Cancer.
Tu Nguyen-Ngoc, Hasna Bouchaab, Alex A Adjei, Solange Peters. J Thorac Oncol 2015

Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.
Scott Kopetz, Jayesh Desai, Emily Chan, Joel Randolph Hecht, Peter J O'Dwyer, Dipen Maru, Van Morris, Filip Janku, Arvind Dasari, Woonbook Chung,[...]. J Clin Oncol 2015

BRAF mutation testing with a rapid, fully integrated molecular diagnostics system.
Filip Janku, Bart Claes, Helen J Huang, Gerald S Falchook, Benoit Devogelaere, Mark Kockx, Isabelle Vanden Bempt, Martin Reijans, Aung Naing, Siqing Fu,[...]. Oncotarget 2015

BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall.
Alessandro Leonetti, Francesco Facchinetti, Giulio Rossi, Roberta Minari, Antonia Conti, Luc Friboulet, Marcello Tiseo, David Planchard. Cancer Treat Rev 2018

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort.
Oliver Gautschi, Julie Milia, Bastien Cabarrou, Marie-Virginia Bluthgen, Benjamin Besse, Egbert F Smit, Juergen Wolf, Solange Peters, Martin Früh, Dieter Koeberle,[...]. J Thorac Oncol 2015

Emerging Biomarkers in Personalized Therapy of Lung Cancer.
Philip T Cagle, Kirtee Raparia, Bryce P Portier. Adv Exp Med Biol 2016

BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment.
Svetlana A Protsenko, Anna I Semionova, Yuri I Komarov, Svetlana N Aleksakhina, Alexandr O Ivantsov, Aglaya G Iyevleva, Evgeny N Imyanitov. Invest New Drugs 2015